首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Oncology reviews

缩写:

ISSN:1970-5565

e-ISSN:1970-5557

IF/分区:4.0/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引310
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Costanza Dieli,Roberta Costanzo,Anna Maria Corsale et al. Costanza Dieli et al.
Glioblastoma multiforme (GBM) remains a highly aggressive brain tumor with limited treatment options and poor survival. The persistent clinical failure has driven interest in novel, immune-based strategies with higher specificity and greate...
M Franco,F Buscema,A Catalano et al. M Franco et al.
Background: The number of people who have experienced cancer is increasing, and by 2040 cases are expected to rise by 40%, with a high prevalence among working-age individuals. Many people who experienced cancer (pwEC) fa...
Yongli Lai,Ruyu Qin,Zhaidong Liu Yongli Lai
The tumor hypercoagulable state (THS) is an acquired and persistent prothrombotic condition driven by the tumor and its microenvironment. An immunosuppressive tumor microenvironment (TME) is a local microenvironment that suppresses antitumo...
Mingyu Zhang,Juhang Chu,Zixin Wang et al. Mingyu Zhang et al.
Breast cancer is the most common malignancy among women worldwide, characterized by pronounced heterogeneity across molecular profiles, imaging phenotypes, and the tumor microenvironment. As precision oncology continues to advance, diagnost...
Putri Dwi Astuti,Eko Adhi Pangarsa,Andreas Arie Setiawan et al. Putri Dwi Astuti et al.
Introduction: Improvements in cancer detection and the development of modern anticancer therapies have markedly increased survival rates among patients with malignancies, resulting in a rapidly expanding survivor populati...
Alyssa Imani,Yan Wisnu Prajoko,Rudi Nirwantono et al. Alyssa Imani et al.
Background: Breast cancer metastasis remains a major contributor to morbidity and mortality, partly due to the disease's marked biological heterogeneity. Identification of reliable biomarkers associated with metastatic pr...
Abdullah Alabbasi,Muhanad Alzahrani,Ziyad Alzahrani et al. Abdullah Alabbasi et al.
Background: Conventional cytotoxic regimens for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) offer limited durable benefit and are associated with significant toxicity. Immune checkpoint inhib...
Akram Al-Ibraheem,Saad Ruzzeh,Ahmad Al-Muhtaseb et al. Akram Al-Ibraheem et al.
Background: Fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography (PET/CT) has emerged as a promising molecular imaging modality with favorable lesion-to-background contrast acros...
Tosin Akinsipe,Caroline O Odewumi,Lekan Latinwo et al. Tosin Akinsipe et al.
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, characterized by a dense desmoplastic stroma and a profoundly immunosuppressive tumor microenvironment (TME). The TME plays a major role in tumor progressi...
Benjamin Konzmann,Maurice Henkel,Christian Breit et al. Benjamin Konzmann et al.
Background: Multidisciplinary tumor boards (MDTs) are the gold standard for cancer care but currently face significant pressure from rising case volumes and the increasing complexity of precision medicine. Large Language ...